loading page

Early and long-term results of bilateral internal thoracic artery grafting in dialysis patients
  • +2
  • Yasuhiko Kawaguchi,
  • Hideki Kitamura,
  • Kazuya Konakano,
  • Mototsugu Tamaki,
  • Yasuhide Okawa
Yasuhiko Kawaguchi
Nagoya Heart Center

Corresponding Author:[email protected]

Author Profile
Hideki Kitamura
Nagoya Heart Center
Author Profile
Kazuya Konakano
Nagoya Heart Center
Author Profile
Mototsugu Tamaki
Nagoya Heart Center
Author Profile
Yasuhide Okawa
Nagoya Heart Center
Author Profile

Abstract

Background: The benefits of bilateral internal thoracic artery (BITA) grafting during coronary artery bypass grafting in dialysis-dependent end-stage renal disease patients remain unclear. We compared the early and long-term effectiveness of coronary artery bypass using BITA versus single internal thoracic artery (SITA) grafting in this population. Methods: Eighty-nine consecutive patients with dialysis-dependent end-stage renal disease who underwent isolated coronary artery bypass grafting were retrospectively analyzed. Early and long-term results were reviewed, and univariate and multivariate analyses of risk factors for late death and major adverse cardiac events (MACE) was performed. Results: There was no significant difference between the BITA (n = 65) and SITA (n = 24) groups in in-hospital mortality (0% vs. 4.2%, p = 0.27) and the incidence of deep surgical wound infection (4.6% vs. 4.2%, p = 1.00). The overall survival rate in the BITA and SITA groups were 90.2% vs. 82.3%, 64.6% vs. 57.6%, and 51.8% vs. 20.6% at 1, 3, and 5 years, respectively. Overall survival was comparable but was more favorable in the BITA group (p = 0.08). MACE-free rate in the BITA and SITA groups were 96.6% vs. 90.2%, 87.4% vs. 60.6%, and 70.1% vs. 51.8% at 1, 3, and 5 years, respectively. The MACE-free rate was significantly higher in the BITA group (p = 0.04). Conclusions: While BITA grafting did not show a significant survival benefit over SITA grafting, it did not increase surgical complications and improve the MACE-free rate. BITA grafting may be a reasonable surgical strategy in dialysis-dependent patients.